Please login to order a test.
Inheritest® Society-guided Screening Panel, NGS
- Pan-ethnic Carrier Screening
Screening for 12 genes, including fragile X carrier screening and spinal muscular atrophy (SMA) carrier screening. This test includes: ASPA, BLM, CFTR, FANCC, FMR1, GBA, HBB, HEXA, IKBKAP, MCOLN1, SMN1 and SMPD1.
Carrier screening for more than 1,200 mutations in 12 genes, including fragile X syndrome and spinal muscular atrophy
Variants known to be benign and synonymous variants not previously recorded in our internal variant database are not reported. This analysis does not detect germline mosaicism, and does not rule out the presence of large chromosomal aberrations including deletions, insertions, and rearrangements, or mutations in regions or genes not included in this test, and possible inter/intragenic interactions between sequence variants. False-positive or false-negative results may occur for reasons that include genetic variants, blood transfusions, bone marrow transplantation, mislabeling of samples, or erroneous representation of family relationships.
This test was developed, and its performance characteristics determined, by Esoterix Genetic Laboratories LLC. It has not been cleared or approved by the US Food and Drug Administration (FDA).
Mutation analysis is performed using the Agilent® SureSelect® XT enrichment method and Illumina® next generation sequencing (NGS) platform. Regions of interest include all exons and splice junctions for each gene. Sequencing reads are aligned with the hg19 build of the human genome reference sequence. Analytical sensitivity is based on the depth of coverage across the regions of interest and is provided separately for each gene. Greater than 98% of target bases are covered at greater than or equal to 20x coverage. Sanger sequencing is used to confirm mutation identity and analyze regions with low coverage. Variants are reported using numbering and nomenclature recommended by the Human Genome Variation Society (HGVS). SureSelect® is a registered trademark of Agilent Technologies. Agilent® is a registered trademark of Agilent Technologies. Illumina® is a registered trademark and registered service mark of Illumina Inc.
Maintain specimen at room temperature or refrigerate at 4°C.
Causes for Rejection
Frozen specimen; hemolysis; quantity not sufficient for analysis; improper container
Test orders must include an attestation that the provider has the patient's informed consent for genetic testing. See sample physician office consent form: Consent for Genetic Testing. Call Integrated Genetics at 855-422-2557 to obtain access to genetic counseling.
|Order Code||Order Code Name||Order Loinc||Result Code||Result Code Name||UofM||Result LOINC|
|451960||Inheritest Society Guided||451999||Genetic Counselor: NGS Inheri||N/A|
|451960||Inheritest Society Guided||451997||Specimen Type: InheriTest||31208-2|
|451960||Inheritest Society Guided||451998||Ethnicity: InheriTest||42784-9|
|451960||Inheritest Society Guided||451618||Indication:||42349-1|
|451960||Inheritest Society Guided||451846||Society Guided Results:||53039-4|
|451960||Inheritest Society Guided||451613||General Comments:||N/A|
|451960||Inheritest Society Guided||451616||Additional Clinical Info||55752-0|
|451960||Inheritest Society Guided||451384||Comments:||77202-0|
|451960||Inheritest Society Guided||451386||Method/Limitations:||49549-9|
|451960||Inheritest Society Guided||451614||Information Table||36908-2|
|451960||Inheritest Society Guided||451333||Disclaimer:||N/A|
|451960||Inheritest Society Guided||451612||Director Review:||72486-4|
|451960||Inheritest Society Guided||451743||51969-4|